SurgiBot

Shares of Transenterix Inc (NYSE: TRXC) were highly volatile on Monday after the company received an update from the U.S. Food and Drug Administration. Transenterix applied for a 510(k) submission with the FDA, which would grant the company marketing clearance for its SurgiBot, a robotically...

Shares of Transenterix Inc (NYSE: TRXC), a medical device company that focuses on robotic assisted surgery, were trading lower by around 15 percent early Wednesday morning after the company announced on Tuesday it plans to offer and sell up to $43.56 million of its common stock. Transenterix...